Searched for
ATIVAN AND PACITANE
Being tactical not an option, but a necessity: Prescription for war and volatility; 7 pharma stocks with upside potential of up to 39%In times of major geopolitical conflicts, there is no point in looking at the day-to-day movement of the Nifty and Sensex. There are some s...- Pharma sector: Reasons to look at it beyond the tariff exemption. 7 pharma stocks with an upside potential of up to 43%Along with semiconductors, electronics and IT, pharma is another sector exempt from the Trump tariffs. Still, as the broader indices declin...
- Nothing wrong in being bullish, if you know why & what you are doing: 7 large-cap stocks with an upside potential of 2 to 20%In the short term, what Trump says, the numbers from China, and what the US Fed does will determine stock prices. But in the long term, the...
- They fall, you catch. One might be a winner in the long term: 8 pharma stocks with upside potential of over 35%Given that the headlines are dominated by what is happening at the border, the street may be forgiven for not noting developments that matt...
- Pfizer shares zoom nearly 9% after marketing and supply agreement with Mylan PharmaceuticalsPfizer shares surged 8.6% to Rs 4,448.35 after announcing a marketing and supply agreement with Mylan Pharmaceuticals for Ativan and Pacita...
- Pfizer board approves marketing, supply pact with Mylan for two brandsPfizer Ltd's board has approved a five-year marketing and supply agreement with Mylan Pharmaceuticals for the brands Ativan and Pacitane, t...
- MNC pharma: Time to re-look at them without bias? 8 MNC pharma stocks, 5 with an upside potential of 15 to 52%While they still trade at premium valuations, they have not created much wealth for shareholders in recent times. The age-old theory that h...
- MNC pharma: Time to relook at them? 8 pharma stocks, 4 with an upside potential of between 16 and 47%In the past four years, several MNC pharma companies announced the sale of a part of their businesses in India. Some of this was part of gl...
- Why predict time and magnitude of correction, focus on business and diversification: 6 large-cap stocks with upside potential of up to 38%After a long time, probably after March 2024, stock prices and the indices have corrected in a very sharp manner – and across the board. Th...
- Indian companies have made a comeback. Will MNCs be able to do it ? 7 MNC pharma stocks with upside potential of up to 21%While they still trade at premium valuations, they have not created wealth for shareholders. The fact is an age-old theory that just having...
- Will the wave of restructuring help? 7 MNC pharma stocks with upside potential of up to 14%In the last three years, Novartis is the third MNC pharma company which has announced sale of a part of its business in India. Some of thes...
- For investors with risk appetite; 5 mid cap stocks with right RoE and upside potential of up to 25%Earning seasons not only helps in judging what is happening to individual companies but more importantly it helps gauge the undercurrent of...
- For risk takers: 5 midcap stocks from different sectors with right RoE and upside potential of up to 30%When valuations are high and sentiments are bullish and earning season is very close, it would be better to add the words like portfolio re...
- For risk takers; 5 midcap stocks from different sectors with right levels of RoE and upside potential of up to 32%Last week, mid-cap stocks saw a sharp correction, because there was no major follow up selling, making the overall trend stay in the bullis...
- Tactical buys in time of correction? 4 MNC pharma stocks with upside potential of up to 28%In the last two decades MNC pharma companies, whose parent companies were setting up 100 percent owned subsidiaries in India and started ro...
- Will they make a comeback? 4 MNC pharma stocks with upside potential of up to 28%After the IT bull of 2000, as a new set of Indian companies took the centerstage, a number of MNCs stocks lost their shine at least on the ...
- Will MNC pharma stocks get back their mojo for good or is it just a blip?Most of the MNC pharma companies have formed their subsidiary and a large majority of new drugs launched in India were via this route. This...
- Long term investing: 6 midcap stocks with high ROE & consistent ROCENothing wrong in getting excited about Nifty moving up, but before one buys they should be clear what they are buying and why they are buyi...
- Long-term wealth creators: 6 midcaps with high ROE & net profit marginAs the Nifty stays in a volatile yet range-bound mode, besides fear of further correction, many investors, especially the ones sitting on c...
- High ROE & net profit margin, 4 stocks with two key elements of long term wealth creatorsThere are some businesses which require a constant dose of capital and banking is one of them. There are some which may require a higher am...
Load More
